ADAPTIMMUNE THERAPEUTICS PLC: accounts_receivable
| Value | {"amount": 1454000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2024-12-31) |
| Status | current |
| Entity | ADAPTIMMUNE THERAPEUTICS PLC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:40:50.704147+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8fe9faf7-40eb-4c8e-baaa-fb7696ddd9c9
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-25-003544 · Open the official SEC filing →Retrieved: 2026-08-19T16:40:50.704147+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001621227/accounts-receivable/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8fe9faf7-40eb-4c8e-baaa-fb7696ddd9c9
History
- no predecessors — first report